Obesity-driven metabolic reprogramming and immune dysfunction in renal cancer - Takeaways - MDSpire

Obesity-driven metabolic reprogramming and immune dysfunction in renal cancer

  • By

  • Henry N. Ogbonna

  • Lyse A. Norian

  • June 11, 2026

  • 0 min

Share

  • 1

    Obesity significantly influences the renal tumor microenvironment in clear cell renal cell carcinoma (ccRCC) through metabolic and inflammatory changes.

  • 2

    Adipose tissue expansion in obesity produces factors that promote tumor growth and immunosuppression, including increased leptin and IL-6.

  • 3

    Obesity reshapes the immune environment in RCC, leading to T cell exhaustion and an increase in regulatory T cells, reinforcing immunosuppression.

  • 4

    The obesity paradox suggests that obesity may correlate with improved treatment outcomes in RCC, complicating the understanding of its effects.

  • 5

    Research priorities include developing obesity-relevant preclinical models and identifying biomarkers for visceral adiposity and systemic inflammation.

Original Source(s)

Related Content